Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens-Peter Volkmer

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Opinion in Urology|July 27, 2010
Cancer stem cells in bladder cancer: a revisited and evolving conceptKeith Syson Chan, Jens-Peter Volkmer, Irving Weissman
Urologic Oncology|September 27, 2008
"Cancer stem cells"-lessons from Hercules to fight the HydraFelix Roman Moltzahn, Jens-Peter Volkmer, Daniel Rottke, et al.
Oncoimmunology|December 10, 2013
Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variantsKipp Weiskopf, Aaron M Ring, Peter J Schnorr, et al.
Oncoimmunology|July 30, 2013
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumorsBadreddin Edris, Stephen Willingham, Kipp Weiskopf, et al.
Frontiers in Oncology|February 11, 2020
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid MalignanciesMark P Chao, Chris H Takimoto, Dong Dong Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2015
CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerMing T Cheah, James Y Chen, Debashis Sahoo, et al.
JCI Insight|May 20, 2020
Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapyJie Liu, Seethu Xavy, Shirley Mihardja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2019
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder CancerBernhard Kiss, Nynke S van den Berg, Robert Ertsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2013
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell responseDiane Tseng, Jens-Peter Volkmer, Stephen B Willingham, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and BtkMingye Feng, James Y Chen, Rachel Weissman-Tsukamoto, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Opinion in Urology|July 27, 2010
Cancer stem cells in bladder cancer: a revisited and evolving conceptKeith Syson Chan, Jens-Peter Volkmer, Irving Weissman
Urologic Oncology|September 27, 2008
"Cancer stem cells"-lessons from Hercules to fight the HydraFelix Roman Moltzahn, Jens-Peter Volkmer, Daniel Rottke, et al.
Oncoimmunology|December 10, 2013
Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variantsKipp Weiskopf, Aaron M Ring, Peter J Schnorr, et al.
Oncoimmunology|July 30, 2013
Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumorsBadreddin Edris, Stephen Willingham, Kipp Weiskopf, et al.
Frontiers in Oncology|February 11, 2020
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid MalignanciesMark P Chao, Chris H Takimoto, Dong Dong Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2015
CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerMing T Cheah, James Y Chen, Debashis Sahoo, et al.
JCI Insight|May 20, 2020
Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapyJie Liu, Seethu Xavy, Shirley Mihardja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2019
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder CancerBernhard Kiss, Nynke S van den Berg, Robert Ertsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2013
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell responseDiane Tseng, Jens-Peter Volkmer, Stephen B Willingham, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
Macrophages eat cancer cells using their own calreticulin as a guide: roles of TLR and BtkMingye Feng, James Y Chen, Rachel Weissman-Tsukamoto, et al.
Pageof 3